Mylan Settles With Sunovion Over Lunesta Generic Plans

Law360, New York (April 2, 2013, 7:47 PM EDT) -- Generic drugmaker Mylan Inc. on Tuesday agreed to a settlement with Sunovion Pharmaceuticals Inc., ending claims that one of its units’ planned generic version of sleep aid Lunesta infringed several Sunovion patents, according to an agreement filed in New Jersey federal court.

Under the terms of the deal, which was approved by U.S. District Judge Susan D. Wigenton, the companies have agreed to drop all claims and counterclaims over whether Mylan unit Alphapharm Pty. Ltd. infringed on Sunovion’s four Lunesta patents — U.S. Patent Numbers 6,319,926;...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.